129 related articles for article (PubMed ID: 33419280)
1. An Investigation into the Relationship between Xanthan Gum Film Coating Materials and Predicted Oro-Esophageal Gliding Performance for Solid Oral Dosage Forms.
Drumond N; Stegemann S
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33419280
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the gliding performance of solid oral dosage form film coatings using an artificial mucous layer.
Drumond N; Stegemann S
Colloids Surf B Biointerfaces; 2019 May; 177():235-241. PubMed ID: 30763788
[TBL] [Abstract][Full Text] [Related]
3. Polymer adhesion predictions for oral dosage forms to enhance drug administration safety. Part 1: In vitro approach using particle interaction methods.
Drumond N; Stegemann S
Colloids Surf B Biointerfaces; 2018 May; 165():9-17. PubMed ID: 29448218
[TBL] [Abstract][Full Text] [Related]
4. Better Medicines for Older Patients: Considerations between Patient Characteristics and Solid Oral Dosage Form Designs to Improve Swallowing Experience.
Drumond N; Stegemann S
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33379258
[TBL] [Abstract][Full Text] [Related]
5. Polymer adhesion predictions for oral dosage forms to enhance drug administration safety. Part 3: Review of in vitro and in vivo methods used to predict esophageal adhesion and transit time.
Drumond N; Stegemann S
Colloids Surf B Biointerfaces; 2018 May; 165():303-314. PubMed ID: 29524806
[TBL] [Abstract][Full Text] [Related]
6. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
[TBL] [Abstract][Full Text] [Related]
7. Polymer adhesion predictions for oral dosage forms to enhance drug administration safety. Part 2: In vitro approach using mechanical force methods.
Drumond N; Stegemann S
Colloids Surf B Biointerfaces; 2018 Jun; 166():17-23. PubMed ID: 29525622
[TBL] [Abstract][Full Text] [Related]
8. Effect of xanthan gum-based food thickeners on the dissolution profile of fluoroquinolones oral formulations.
Takahashi N; Fujita Y; Takahashi N; Nakamura A; Harada T
J Pharm Health Care Sci; 2020 Nov; 6(1):25. PubMed ID: 33292643
[TBL] [Abstract][Full Text] [Related]
9. Effect of Gellan Gum and Xanthan Gum Synergistic Interactions and Plasticizers on Physical Properties of Plant-Based Enteric Polymer Films.
Zhang N; Li X; Ye J; Yang Y; Huang Y; Zhang X; Xiao M
Polymers (Basel); 2020 Jan; 12(1):. PubMed ID: 31948039
[TBL] [Abstract][Full Text] [Related]
10. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
Iwanaga K; Ono S; Narioka K; Kakemi M; Morimoto K; Yamashita S; Namba Y; Oku N
J Pharm Sci; 1999 Feb; 88(2):248-52. PubMed ID: 9950646
[TBL] [Abstract][Full Text] [Related]
11. A novel soft robotic pediatric in vitro swallowing device to gain insights into the swallowability of mini-tablets.
Lavoisier A; Avila-Sierra A; Timpe C; Kuehl P; Wagner L; Tournier C; Ramaioli M
Int J Pharm; 2022 Dec; 629():122369. PubMed ID: 36351507
[TBL] [Abstract][Full Text] [Related]
12. Oral controlled release formulation for highly water-soluble drugs: drug--sodium alginate--xanthan gum--zinc acetate matrix.
Zeng WM
Drug Dev Ind Pharm; 2004 May; 30(5):491-5. PubMed ID: 15244084
[TBL] [Abstract][Full Text] [Related]
13. The behavior of hydrocolloid coatings on vegetative materials.
Hershko V; Nussinovitch A
Biotechnol Prog; 1998 Sep; 14(5):756-65. PubMed ID: 9758666
[TBL] [Abstract][Full Text] [Related]
14. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
Moroni A; Drefko W; Thone G
Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules.
Castro PM; Sousa F; Magalhães R; Ruiz-Henestrosa VMP; Pilosof AMR; Madureira AR; Sarmento B; Pintado ME
Carbohydr Polym; 2018 Aug; 194():411-421. PubMed ID: 29801856
[TBL] [Abstract][Full Text] [Related]
16. The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water.
Perkins AC; Wilson CG; Frier M; Blackshaw PE; Dansereau RJ; Vincent RM; Wenderoth D; Hathaway S; Li Z; Spiller RC
Int J Pharm; 2001 Jul; 222(2):295-303. PubMed ID: 11427359
[TBL] [Abstract][Full Text] [Related]
17. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis.
Mundargi RC; Patil SA; Agnihotri SA; Aminabhavi TM
Drug Dev Ind Pharm; 2007 Mar; 33(3):255-64. PubMed ID: 17454058
[TBL] [Abstract][Full Text] [Related]
18. Mechanism and Impact of Excipient Incompatibility: Cross-Linking of Xanthan Gum in Pediatric Powder-for-Suspension Formulations.
Li Y; Zhang D; Ash J; Jia X; Leone A; Templeton A
J Pharm Sci; 2019 Nov; 108(11):3609-3615. PubMed ID: 31348935
[TBL] [Abstract][Full Text] [Related]
19. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
20. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
